3QTX
CDK2 in complex with inhibitor RC-2-35
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 93 |
Detector technology | IMAGE PLATE |
Collection date | 2009-02-03 |
Detector | RIGAKU |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.660, 71.730, 72.570 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 18.790 - 1.950 |
R-factor | 0.2 |
Rwork | 0.200 |
R-free | 0.24600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1pw2 |
RMSD bond length | 0.007 |
RMSD bond angle | 1.300 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | CNS (1.2) |
Refinement software | CNS (1.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 2.000 |
High resolution limit [Å] | 1.950 | 1.950 |
Rmerge | 0.067 | 0.293 |
Number of reflections | 20992 | |
<I/σ(I)> | 19.58 | 6.71 |
Completeness [%] | 99.8 | 100 |
Redundancy | 6.86 | 6.83 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7.5 | 291 | 5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K |